Page last updated: 2024-10-24

bupivacaine and Pulmonary Fibrosis

bupivacaine has been researched along with Pulmonary Fibrosis in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winning, AJ1
Hamilton, RD1
Guz, A1

Trials

1 trial available for bupivacaine and Pulmonary Fibrosis

ArticleYear
Ventilation and breathlessness on maximal exercise in patients with interstitial lung disease after local anaesthetic aerosol inhalation.
    Clinical science (London, England : 1979), 1988, Volume: 74, Issue:3

    Topics: Aerosols; Aged; Bupivacaine; Exercise Test; Humans; Lung; Male; Middle Aged; Physical Exertion; Pulm

1988